Due to its strategic location, Utrecht is a magnet for the logistics sector. The combination of being centrally situated in the middle of the Netherlands and great accessibility of all transport modes is unique. The city is close to international airport Schiphol and is located at the Crossroads of the Netherlands’ main railways, highways and waterways. In the port Lage Weide, the city has one of the largest inland ports of the Netherlands, including container transshipment.
Utrecht region ranks second place in the logistic locations listing (JLL 2017) and scores particularly high in occupancy rate and new development. Utrecht is a central location for national distribution and demand as a result of e-commerce in Utrecht and other large cities is growing steadily. Recently, Picnic established its office in Lage Weide. This company delivers groceries using electric cars. Since the transportation of goods is increasing, sustainability is gaining importance. Gains can be made in using sustainable means of transport as well as bundling traffic. For example, in 2017, a construction hub was opened in Lage Weide, where construction material is ‘collected’ and combined before delivery to the construction site, resulting in a significant reduction of transport.
Utrecht invests in high-quality types of logistics with high labor intensity and added value. For large-scale logistics, together we will search for a suitable solution, either within or outside the region.
“Utrecht is the perfect base being central to the country and enables us to employ talented people from all over the Netherlands and across Europe and rest of world that can easily access Schiphol.”
-Stephan Sieber, CEO Unit4
“We have deliberately chosen to stay in Utrecht. The central location and accessibility, both by car and public transport, make the city the best place to have our headquarters.”
-Emlyn van der Wal, Chief Operating Officer at ABN AMRO Lease
“Genmab regards Utrecht Science Park as a unique ecosystem, where innovation actively leads to breakthroughs in the development of new medicines.”
-Yvo Graus, Vice President Pre-Clinical Operations at Genmab